Stock 1541 IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Equities

1541

CNE100006624

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:05 2024-07-18 am EDT 		5-day change 1st Jan Change
12.9 HKD +0.31% Intraday chart for ImmuneOnco Biopharmaceuticals (Shanghai) Inc. -0.62% -56.86%
Jul. 03 ImmuneOnco Doses First Patient in Phase 3 Clinical Trial of Hodgkin Lymphoma Drug MT
Jul. 03 ImmuneOnco Biopharmaceuticals Inc. Announces Updates on the Clinical Trial of IMM01 (Timdarpacept) in Combination with Tislelizumab CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. Stock ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
 616M - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 117B
ARGENX SE Stock argenx SE
 27.52B -
BIONTECH SE Stock BioNTech SE
 20.87B -
GENMAB A/S Stock Genmab A/S
 17.01B
  1. Stock Market
  2. Equities
  3. 1541 Stock
  4. Charts ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
  5. Sector Chart